103 filings
Page 4 of 6
8-K
ebnxo8n xa
6 Jul 06
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
12:00am
8-K
1ksdw hxup
22 May 06
AtheroGenics Announces Dismissal of Class Action Litigation
12:00am
8-K
2uyaylb45vpacw24nsu
20 Apr 06
AtheroGenics Reports First Quarter 2006 Financial Results
12:00am
8-K
58fpa
10 Mar 06
Entry into a Material Definitive Agreement
12:00am
8-K
a2qvyt8jke3ka vqq7
28 Feb 06
AtheroGenics Reports Fourth Quarter and Year-End 2005 Financial Results
12:00am
8-K
3n6fck
11 Jan 06
Unregistered Sales of Equity Securities
12:00am
8-K
1qyppu
22 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
quhq tiba
20 Oct 05
AtheroGenics Reports Third Quarter 2005 Financial Results
12:00am
8-K
bc4066
10 Aug 05
Entry into a Material Definitive Agreement
12:00am
8-K
03avmngqavvz
22 Jul 05
Entry into a Material Definitive Agreement
12:00am
8-K
51dkrt
21 Jul 05
AtheroGenics Reports Second Quarter 2005 Financial Results
12:00am
8-K
ziqd271sqykw5ktozf
15 Jul 05
Other Events
12:00am
8-K
nt97d3t6u4
7 Jul 05
Entry into a Material Definitive Agreement
12:00am
8-K
3q71o7
29 Apr 05
Entry into a Material Definitive Agreement
12:00am
8-K
6f1jr3vxo9s5pvdc7
21 Apr 05
AtheroGenics Reports First Quarter 2005 Financial Results
12:00am
8-K
c9nslr
22 Feb 05
AtheroGenics Receives FDA Approval for Protocol Amendment to ARISE Phase III Clinical Trial
12:00am
8-K
vyhh29arm
16 Feb 05
AtheroGenics Reports Fourth Quarter and Full-Year 2004 Financial Results
12:00am
8-K
4bbva38h6k3
13 Jan 05
Entry into a Material Definitive Agreement
12:00am
8-K
ofgk4lc0hp
11 Jan 05
Other Events
12:00am
8-K
y0q xrzljng
7 Jan 05
AtheroGenics Prices Private Offering of Convertible Notes
12:00am